|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
6
|
Resverlogix Corp.
|
Jun 13, 2023 09:08AM
|
|
Thoughts re FDA approvals
|
6
|
Resverlogix Corp.
|
Nov 23, 2015 07:32PM
|
|
Re: Enthusiasm? NOT!
|
6
|
Zenith Epigenetics
|
Oct 30, 2021 12:56PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
6
|
Resverlogix Corp.
|
Sep 06, 2017 04:59PM
|
|
Re: Question
|
6
|
Resverlogix Corp.
|
Feb 25, 2021 01:09PM
|
|
Covid
|
6
|
Resverlogix Corp.
|
Aug 12, 2022 12:09PM
|
|
Re: Long term risks associated with covid
|
6
|
Resverlogix Corp.
|
Jan 06, 2022 12:23PM
|
|
Re: Just back from IR,...
|
6
|
Resverlogix Corp.
|
Oct 26, 2019 11:07AM
|
|
Re: Looks like...
|
6
|
Resverlogix Corp.
|
Feb 03, 2021 11:50AM
|
|
Re: Where's the kool aid gang?
|
6
|
Resverlogix Corp.
|
May 20, 2022 05:43PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
6
|
Zenith Epigenetics
|
Sep 26, 2024 04:49PM
|
|
Missed Opportunity
|
6
|
Resverlogix Corp.
|
Apr 01, 2024 05:20PM
|
|
Re: Thoughts re FDA approvals
|
6
|
Resverlogix Corp.
|
Nov 24, 2015 07:50PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
6
|
Zenith Epigenetics
|
Feb 07, 2022 12:27PM
|
|
Re: Zenith a Loser Too
|
6
|
Resverlogix Corp.
|
Jun 17, 2020 06:59AM
|
|
Re: Metablock
|
6
|
Resverlogix Corp.
|
Dec 06, 2021 05:23PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
6
|
Resverlogix Corp.
|
May 14, 2020 09:33AM
|
|
Re: A quick note of comparison vis a vis CEO salaries....
|
6
|
Resverlogix Corp.
|
Aug 28, 2015 07:43PM
|
|
Re: Another reason
|
6
|
Resverlogix Corp.
|
Jan 10, 2022 05:19PM
|
|
Re: Don's April 14th Interview on the Drive
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 11:15AM
|
